Tirzepatide is a dual GIP/GLP-1 receptor agonist used for type 2 diabetes and chronic weight management. Administered via weekly injection, it improves blood sugar control and promotes significant weight loss. Adults with obesity or excess weight alongside related conditions benefit most, under medical supervision.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·This Month's Top Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends